Sangamo Therapeutics Inc (NASDAQ:SGMO) - Share price - Overview

Stock Report

Sangamo Therapeutics Inc SGMO

Last Price
$8.79

Day Change
-0.21|-2.33%

As of 15/02/2019
17:59:23 EST | USD
Minimum 15 Minutes Delay.

Last Close9.00
Day Range8.77 - 9.12
Mkt Cap897.40Mil
52-Wk Range6.26 - 27.50
Yield %-
ISINUS8006771062
Volume1,804,259
P/E-13.12
P/S11.51
P/CF13.59

Share Price

Financials
201520162017
More ...
Income Statement
Revenue39.5419.3936.57
Operating Income-46.86-72.56-56.36
Net Income-40.70-71.66-54.57
Basic EPS-0.58-1.02-0.70
Avg. Diluted Shares Outstanding707178
Balance Sheet
Current Assets212.58149.58248.40
Non Current Assets4.658.3138.34
Total Assets217.24157.89286.74
Current Liabilities20.1013.2944.86
Total Liabilities---
Total Equity192.44136.20187.90
Cash Flow
Operating Cash Flow-33.72-65.8811.18
Capital Expenditure-2.41-0.73-3.75
Free Cash Flow-36.13-66.627.43

In millions, except "Basic EPS". Currency is USD.

Company Profile

Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

234
Key Stats
More ...
Price/Earning TTM-13.43
Price/Book2.42
Price/Sales TTM11.79
Rev Growth (3 year avg)-7.28
EPS Growth (3 year avg)-
Operating Margin % TTM-154.13
Net Margin % TTM-149.23
ROE TTM-33.67
Debt/Equity0.13
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.